Reducing cancer costs and improving quality through collaboration with payers: A proposal from the florida society of clinical oncology

Journal of Oncology Practice

Volumn 6, Issue 5, 2010, Pages 265-269

  Marsland, Thomas ^a   Robbins, Gerald ^a   Marks, Alan ^a   Cassell, Robert ^a   Philips, Dorothy Green ^a   King, Kristen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ASTHMA; CANCER STAGING; CLINICAL PATHWAY; CLINICAL PRACTICE; COST CONTROL; DISEASE MANAGEMENT; DRUG UTILIZATION; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEART FAILURE; HOSPICE CARE; HUMAN; MEDICAL CARE; MEDICAL EDUCATION; MEDICARE; NEOPLASM; PATIENT CARE; PATIENT GUIDANCE; PRIVATE PRACTICE; PROFESSIONAL STANDARD; PUBLIC-PRIVATE PARTNERSHIP; QUALITY OF LIFE; REIMBURSEMENT; REVIEW; TERMINAL CARE; TOTAL QUALITY MANAGEMENT; TRAUMATIC BRAIN INJURY; UNITED STATES;

EID: 78751509136     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.000062     Document Type: Review

References (27)

1. Keehan S, Sisko A, Truffer C, et al: Health spending projections through 2017: The baby-boom generation is coming to Medicare. Health Aff (Millwood) 27:w145-w155, 2008 (Pubitemid 351490375)
2. Meropol NJ, Schrag D, Smith TJ, et al: American Society of Clinical Oncology guidance statement: The cost of cancer care. J Clin Oncol 27:3868-3874, 2009
3. Anderson GF, Hussey PS, Frogner BK, et al: Health spending in the United States and the rest of the industrialized world. Health Aff (Millwood) 24:903-914, 2005
4. Anderson GF, Frogner BK, Reinhardt UE: Health spending in OECD countries in 2004: An update. Health Aff (Millwood) 26:1481-1489, 2007
5. Anderson GF, Frogner BK, Johns RA, et al: Health care spending and use of information technology in OECD countries. Health Aff (Millwood) 25:819-831, 2006 (Pubitemid 43824933)
6. Reinhardt UE, Hussey PS, Anderson GF: US health care spending in an international context. Health Aff (Millwood) 23:10-25, 2004
7. Anderson GF, Frogner BK: Health spending in OECD countries: Obtaining value per dollar. Health Aff (Millwood) 27:1718-1727, 2008
8. American Cancer Society: Cancer Facts & Figures 2008. Atlanta, GA, American Cancer Society, 2008
9. Mulcahy N: Time to consider cost in evaluating cancer drugs in United States? Medscape Medical News, 2009 July 14. http://www.medscape.com/ viewarticle/705689
10. Fojo T, Grady C: How much is life worth: Cetuximab, non-small cell lung cancer, and the $440 billion question. J Natl Cancer Inst 101:1044-1048, 2009
11. Medicare and Medicaid Programs; Electronic Health Records Incentive Program; Proposed Rule. 42 CFR Parts 412, et al (2010). http://edocket.access. gpo.gov/2010/pdf/E9-31217.pdf
12. Association of Community Cancer Centers: ACCC's 5th Annual Hospital Summit: Meeting wrap-up. http://accc-cancer.org/meetings/meetings- hospitalsummit2009.asp
13. Vokes EE, Schilsky RL, Kyung E, et al: A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer. Cancer 63:30-36
14. Menéndez R, Reyes S, Martínez R, et al: Economic evaluation of adherence to treatment guidelines in nonintensive care pneumonia. Eur Respir J 29:751-756, 2007 (Pubitemid 46554626)
15. Fritz JM, Cleland JA, Brennan GP: Does adherence to the guideline recommendation for active treatments improve the quality of care for patients with acute low back pain delivered by physical therapists? Med Care 45:973-980, 2007
16. Faul M, Wald MM, Rutland-Brown W, et al: Using a cost-benefit analysis to estimate outcomes of a clinical treatment guideline: Testing the Brain Trauma Foundation guidelines for the treatment of severe traumatic brain injury. J Trauma 63:1271-1278, 2007
17. Fakhry SM, Trask AL, Waller MA, et al: Management of brain-injured patients by an evidence-based medicine protocol improves outcomes and decreases hospital charges. J Trauma 56:492-499, 2004; discussion 499-500
18. Didomenico RJ, Perez A, Schumann HM, et al: Impact of treatment guidelines on clinical and economic outcomes of acute decompensated heart failure. Ann Pharmacother 42:327-333, 2008 (Pubitemid 351429596)
19. Carlson B: Controlling the cost of care through clinical pathways. Biotechnol Healthc 6:23-26, 2009
20. Butcher L: Can insurer, oncology practice really work together? Premera Blue Cross and a large Spokane oncology practice agree on treatment protocols and on the importance of cost control. Managed Care, Oct 2007. http://www.managedcaremag.com/archives/0710/0710.cancercollab.html
21. Neubauer MA, Hoverman JR, Kolodziej M, et al: Cost effectiveness of evidence- based treatment guidelines for the treatment of non-small-cell lung cancer in the community setting. J Oncol Pract 6:12-18, 2010
22. Chernew ME, Shah MR, Wegh A, et al: Impact of decreasing copayments on medication adherence within a disease management environment. Health Aff 27:103-112, 2008 (Pubitemid 351198595)
23. Raphael C, Ahrens J, Fowler N: Financing end-of-life care in the USA. J R Soc Med 94:458-461, 2001
24. Lubitz JD, Riley GF: Trends in Medicare payments in the last year of life. N Engl J Med 328:1092-1096, 1993
25. Emanuel EJ, Young-Xu Y, Levinsky NG, et al: Chemotherapy use among Medicare beneficiaries at the end of life. Ann Intern Med 138:639-643, 2003 (Pubitemid 38124655)
26. Taylor DH Jr, Ostermann J, Van Houtven CH, et al: What length of hospice use maximizes reduction in medical expenditures near death in the US Medicare program? Soc Sci Med 65:1466-1478, 2007
27. Taylor DH Jr: The effect of hospice on Medicare and informal care costs: The U.S. experience. J Pain Symptom Manage 38:110-114, 2009